Company Profiles

driven by the PitchBook Platform

Metamark Genetics

Description

Developer of prognostic and predictive diagnostic tests designed to help personalized treatment planning for cancer patients. The company's prognostic and predictive diagnostic tests will evaluate the genetic profile of an individual patient's tumor and determine the expression of Metamark's proprietary Prognosis Determinants. Based on data generated through clinical validation studies, individual tumors which will be analyzed to determine the individual patient's risk of recurrence, enabling the patient and his or her physician to develop an individualized treatment plan.

2007

Founded

PRIVATE

Status

51-200

Employees

Series B

Latest Deal Type

$13M

Latest Deal Amount

$48M

Total Amount Raised

Description

Developer of prognostic and predictive diagnostic tests designed to help personalized treatment planning for cancer patients. The company's prognostic and predictive diagnostic tests will evaluate the genetic profile of an individual patient's tumor and determine the expression of Metamark's proprietary Prognosis Determinants. Based on data generated through clinical validation studies, individual tumors which will be analyzed to determine the individual patient's risk of recurrence, enabling the patient and his or her physician to develop an individualized treatment plan.

Website:

www.metamarkgenetics.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Monitoring Equipment

Primary Office

283 Bear Hill Road Waltham, MA 02451United States +1 (617) 583-1400
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Metamark Genetics's full profile, request a free trial.

    Metamark Genetics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Metamark Genetics Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Chione InvestmentsCorporationMinority000 0000000 0000
    Chione Investments Corporation

    Metamark Genetics Executive Team (11)

    NameTitleBoard
    Seat
    Contact
    Info
    Peter MaimonisChief Scientific Officer & Senior Vice President, Research & Development
    David Rimm Ph.DConsultant & Co-Founder
    Michael HoffmanDirector of National Accounts
    Kenneth WegCo-Founder, President, Chief Executive Officer & Chairman
    Lynda Chin MDScientific Founder
    Peter Maimonis Chief Scientific Officer & Senior Vice President, Research & Development
    David Rimm Ph.D Consultant & Co-Founder
    Michael Hoffman Director of National Accounts
    Kenneth Weg Co-Founder, President, Chief Executive Officer & Chairman
    Lynda Chin MD Scientific Founder

    Metamark Genetics Board Members (6)

    NameRepresentingRoleSinceContact
    Info
    Gregory Critchfield MDSelfBoard Member000 0000
    Kenneth WegMetamark GeneticsCo-Founder, President, Chief Executive Officer & Chairman000 0000
    Mansoor Mirza MDSelfBoard Member000 0000
    Michael Kauffman Ph.DSelfBoard Member000 0000
    Norman SelbySelfBoard Member000 0000
    Gregory Critchfield MD Board Member Self
    Kenneth Weg Co-Founder, President, Chief Executive Officer & Chairman Metamark Genetics
    Mansoor Mirza MD Board Member Self
    Michael Kauffman Ph.D Board Member Self
    Norman Selby Board Member Self
    Request full access to PitchBook